Complement-dependent cytotoxicity

Complement-dependent cytotoxicity is when antibodies bind a cell surface, activate the complement system, and trigger that cell's destruction. In Immunobiology, it is a classic mechanism in Type II hypersensitivity.

What is Complement-dependent cytotoxicity?

Complement-dependent cytotoxicity, or CDC, is a way the immune system kills a target cell after antibodies latch onto antigens on its surface. Once the antibody is bound, the complement system can be activated, and the cell may be damaged, marked for removal, or lysed outright. In Immunobiology, this comes up most often when you are tracing how antibodies turn from simple binders into active cell-killing tools.

The usual setup starts with IgG or IgM attached to a cell membrane. That antibody binding acts like a flag for the classical complement pathway. Complement proteins then assemble in a cascade, which can end in the membrane attack complex, or MAC, punching holes in the target cell membrane.

That pore formation is the part that earns the name cytotoxicity. If enough MAC forms, water and ions move uncontrollably across the membrane, the cell loses integrity, and lysis follows. But CDC is not only about immediate bursting. Complement fragments can also coat the cell and make it easier for phagocytes to clear it away, so destruction and clearance often work together.

This mechanism is most obvious in type II hypersensitivity, where antibodies target antigens on specific cells or tissues instead of free-floating material. A classic example is a transfusion reaction from mismatched blood, where antibodies in the recipient recognize donor red blood cell antigens and trigger complement-mediated destruction. The same logic can appear in autoimmune hemolytic anemia, where the body's own red cells become the target.

CDC also shows up outside disease. Some therapeutic monoclonal antibodies are designed to recruit complement and kill cancer cells more efficiently. In that setting, the antibody is not just blocking a receptor, it is helping the immune system turn a target cell into a complement target.

Why Complement-dependent cytotoxicity matters in IMMUNOBIOLOGY

Complement-dependent cytotoxicity is one of the cleanest examples of how antibodies do more than bind. In Immunobiology, it connects antigen recognition, the complement cascade, membrane damage, and cell removal into one pathway you can trace from start to finish.

It also gives you a framework for understanding type II hypersensitivity. When a reaction is directed at cells already in the body, you need to know whether the damage comes from complement lysis, opsonization and phagocytosis, or both. CDC is the piece that explains why some antibody reactions lead to direct cell death instead of just inflammation.

This term also shows up in clinical reasoning. If a case mentions mismatched blood, hemolysis, or autoantibodies against red blood cells, CDC is usually part of the mechanism. If the prompt shifts to monoclonal antibody therapy, CDC can explain how a treatment recruits innate immune machinery to remove a target cell.

So when you see CDC, think mechanism first: antibody binds, complement activates, membrane gets attacked, cell is damaged or lysed. That sequence is the bridge between molecular immunology and disease symptoms.

How Complement-dependent cytotoxicity connects across the course

Complement System

CDC depends on the complement cascade being activated after antibodies bind a target cell. The complement system supplies the proteins that amplify the signal and build the membrane attack complex. If you understand the cascade, CDC makes much more sense as a downstream effect rather than a separate immune event.

Opsonization

Opsonization and CDC can happen in the same antibody response, but they do not do exactly the same job. Opsonization tags a cell so phagocytes can eat it, while CDC can directly damage the membrane through MAC formation. A question may ask you to distinguish tagging from lysis.

Type II Hypersensitivity

CDC is one of the main mechanisms behind Type II hypersensitivity, where antibodies target antigens on cells or tissues. The reaction is not against a soluble allergen, and it is not a T cell driven response. Instead, the antibody plus complement pathway causes damage to the targeted cell.

autoimmune hemolytic anemia

This condition is a strong example of how CDC can become harmful. Autoantibodies bind red blood cells, complement gets activated, and the cells can be destroyed in circulation or cleared from the blood. It is a useful case for linking immune mechanisms to anemia symptoms.

Is Complement-dependent cytotoxicity on the IMMUNOBIOLOGY exam?

A quiz question or case prompt may give you a blood transfusion mismatch, an autoantibody, or a monoclonal antibody therapy and ask what mechanism is causing cell damage. Your job is to identify the antibody bound to the target cell, then trace complement activation to MAC formation or complement tagged clearance. If the prompt asks why the cell is lysing, CDC is the mechanism you name. If it asks for the broader category, connect it to Type II hypersensitivity. In a lab or diagram question, you may need to recognize the sequence, antibody binding first, complement next, then membrane injury or phagocytic removal. On short responses, use the full chain instead of just saying

Key things to remember about Complement-dependent cytotoxicity

• Complement-dependent cytotoxicity is antibody-triggered cell killing through the complement system.

• The classic sequence is antibody binding, complement activation, membrane attack complex formation, and cell lysis or clearance.

• CDC is a major mechanism in Type II hypersensitivity because the antibodies target cells or tissues directly.

• Mismatched transfusions and autoimmune hemolytic anemia are common examples of CDC in action.

• Some monoclonal antibody therapies use CDC on purpose to help destroy cancer cells.

Frequently asked questions about Complement-dependent cytotoxicity

What is complement-dependent cytotoxicity in Immunobiology?

It is a mechanism where antibodies bind a target cell and activate complement, which can damage or lyse that cell. In Immunobiology, it is a classic example of how the adaptive immune system can recruit innate complement proteins to kill cells.

How does complement-dependent cytotoxicity kill cells?

Antibody binding starts the classical complement pathway, which leads to membrane attack complex formation on the target cell. The MAC creates pores in the membrane, and that can cause cell lysis. Complement fragments can also help mark the cell for removal.

Is complement-dependent cytotoxicity the same as opsonization?

No. Opsonization tags a cell so phagocytes can engulf it more easily, while CDC can directly damage the membrane and cause lysis. The two often work together in the same immune response, but they are not the same outcome.

What is an example of complement-dependent cytotoxicity?

A mismatched blood transfusion is a classic example. Antibodies in the recipient can recognize antigens on donor red blood cells, activate complement, and contribute to hemolysis. Autoimmune hemolytic anemia uses the same basic mechanism against the body's own red cells.